会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • 글루타메이트 시냅스 반응 향상을 위한 3-치환된 1,2,3-트리아진-4-온 및 3-치환된 1,3-피리미디논
    • 3-取代的1,2,3-三嗪-4-酮和3-取代的1,3-吡啶酮用于增强谷氨酸反应性
    • KR1020100063087A
    • 2010-06-10
    • KR1020107006440
    • 2008-09-19
    • 코텍스 파마슈티칼스, 인크.
    • 뮐러,루돌프스트릿,레슬리,제이.레크웰,스테니스러우알리살라,캐쉬네탐
    • C07D255/04C07D239/88C07D487/04
    • C07D487/04
    • This invention relates to compounds, pharmaceutical compositions and methods for use in the prevention and treatment of cerebral insufficiency, including enhancement of receptor functioning in synapses in brain networks responsible for basic and higher order behaviors. These brain networks, which are involved in regulation of breathing, and cognitive abilities related to memory impairment, such as is observed in a variety of dementias, in imbalances in neuronal activity between different brain regions, as is suggested in disorders such as Parkinson's disease, schizophrenia, respiratory depression, sleep apneas, attention deficit hyperactivity disorder and affective or mood disorders, and in disorders wherein a deficiency in neurotrophic factors is implicated, as well as in disorders of respiration such as overdose of an alcohol, an opiate, an opioid, a barbiturate, an anesthetic, or a nerve toxin, or where the respiratory depression results form a medical condition such as central sleep apnea, stroke-induced central sleep apnea, obstructive sleep apnea, congenital hypoventilation syndrome, obesity hypoventilation syndrome, sudden infant death syndrome, Rett syndrome, spinal cord injury, traumatic brain injury, Cheney-Stokes respiration, Ondines curse, Prader-Willi's syndrome and drowning. In a particular aspect, the invention relates to compounds useful for treatment of such conditions, and methods of using these compounds for such treatment.
    • 本发明涉及用于预防和治疗脑功能不全的化合物,药物组合物和方法,包括增强负责基本和高级行为的脑网络突触中的受体功能。 涉及呼吸调节的这些脑网络,以及与记忆障碍有关的认知能力,例如在各种痴呆症中观察到的,在不同脑区域之间的神经元活动不均衡中,如在帕金森病, 精神分裂症,呼吸抑制,睡眠呼吸暂停,注意缺陷多动障碍和情感或情绪障碍,以及涉及神经营养因子缺乏的疾病,以及呼吸障碍,例如过量的酒精,阿片剂,阿片样物质, 巴比妥酸盐,麻醉剂或神经毒素,或呼吸抑制结果形成中枢性睡眠呼吸暂停,中风引起的中枢性睡眠呼吸暂停,阻塞性睡眠呼吸暂停,先天性通气不足综合征,肥胖低通气综合征,婴儿猝死综合征 ,Rett综合征,脊髓损伤,创伤性脑损伤,Cheney-Stokes呼吸,Ondines诅咒 ,Prader-Willi综合征和溺水。 在一个特定方面,本发明涉及可用于治疗这些病症的化合物,以及使用这些化合物进行这种治疗的方法。